Invention Grant
- Patent Title: Neprilysin inhibitors
- Patent Title (中): Neprilysin抑制剂
-
Application No.: US13869174Application Date: 2013-04-24
-
Publication No.: US08846913B2Publication Date: 2014-09-30
- Inventor: Melissa Fleury , Roland Gendron , Adam D. Hughes , Cameron Smith
- Applicant: Theravance, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Shelley Eberle
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D239/36 ; C07D249/18 ; C07D249/04 ; C07D249/10 ; C07D231/14 ; C07D403/04 ; C07D261/12 ; C07D231/20 ; C07D257/04 ; C07D471/04 ; C07C271/22 ; C07C243/28
Abstract:
In one aspect, the invention relates to compounds having the formula: where R1, R2a, R2b, R3—R6, a, b, Z, and X are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
Public/Granted literature
- US20130245260A1 NEPRILYSIN INHIBITORS Public/Granted day:2013-09-19
Information query
